Then, MDSCs circulate in the blood and spleen and eventually home to tumor sites, in which factors such as interleukin (IL-10) and transforming growth factor beta (TGFβ) secreted by MDSCs accelerate tumor growth by impeding antitumor activity and promoting suppressive cell differentiation [8,9]. The gene discussed is IL10; the disease is neoplasm.